image
Pieris Pharmaceuticals, Inc. PIRS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 15.8679
-0.202 %
$ 21 M
Market Cap
-0.83
P/E
INCOME STATEMENT
42.8 M REVENUE
65.28%
Growth Rates
1Year 65.28%
3Years 13.44%
5Years 8.03%
7Years 32.95%
10Years 15.79%
-29.8 M OPERATING INCOME
31.55%
Growth Rates
1Year 31.55%
3Years 4.27%
5Years 0.71%
7Years -3.90%
10Years -49.22%
-24.5 M NET INCOME
26.25%
Growth Rates
1Year 26.25%
3Years 12.97%
5Years 1.71%
7Years -1.06%
10Years -80.73%
EFFICIENCY
Earnings Waterfall Pieris Pharmaceuticals, Inc.
image
Revenue 42.8 M
Cost Of Revenue 41.8 M
Gross Profit 1.01 M
Operating Expenses 72.6 M
Operating Income -29.8 M
Other Expenses -5.21 M
Net Income -24.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 42.8 25.9 31.4 29.3 46.3 29.1 25.3 5.8 2.9 5.4 9.9 11.4
GROSS PROFIT
Cost Of Revenue 41.8 2.8 2.4 46.5 55.0 0 0 0 0 0 (2.5) 0
Gross Profit 1.0 23.1 29.1 (17.2) (8.7) 29.1 25.3 5.8 2.9 5.4 12.4 11.4
OPERATING INCOME
Operating Expenses 72.6 61.2 79.6 63.2 73.4 59.9 39.9 28.6 16.6 12.6 9.3 13.5
Selling, General and Administrative Expenses 16.9 16.4 16.6 16.7 18.4 18.4 17.6 8.9 8.4 7.0 2.5 3.0
Research and Development Expenses 41.8 53.0 66.7 46.5 55.0 41.5 22.3 19.7 8.2 5.6 9.4 10.9
Operating Income (29.8) (43.5) (51.8) (33.9) (27.2) (30.8) (14.6) (22.8) (13.7) (7.2) 0.6 (2.2)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0 0 0 1.9 2.32 K 0.2 2.7 0.5 0
Total Other Income 5.2 10.2 6.1 (3.1) 1.7 3.8 (1.9) 0.1 (0.2) (2.7) (0.5) (0.1)
Pre-Tax Income (24.5) (33.3) (45.7) (37.1) (25.5) (27.1) (16.5) (22.6) (13.9) (9.8) 66.2 K (2.3)
NET INCOME
Tax Provision 0 (2.0) (2.4) 0.2 (1.7) (0.3) 1.1 0.2 0.2 18 0.5 22
Net Income (24.5) (31.3) (43.4) (37.2) (23.8) (26.8) (17.6) (22.8) (14.1) (9.8) 66.2 K (2.3)
EPS 21.8 33.7 53.8 54.7 37.5 40.3 32.1 43.7 32.7 20.6 0.45 38.7